Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-02T15:48:10.542Z Has data issue: false hasContentIssue false

Gender and activation level in smokers

Published online by Cambridge University Press:  16 April 2020

E. Daurignac*
Affiliation:
CNRS UMR 7593, Pavillon Clérambault, Hôpital de la Salpêtrière, 47, Bd. de l'H ôpital, 75013, Paris, France
F. Perez-Diaz
Affiliation:
CNRS UMR 7593, Pavillon Clérambault, Hôpital de la Salpêtrière, 47, Bd. de l'H ôpital, 75013, Paris, France
C. Grillon
Affiliation:
CNRS UMR 7593, Pavillon Clérambault, Hôpital de la Salpêtrière, 47, Bd. de l'H ôpital, 75013, Paris, France
R. Jouvent
Affiliation:
CNRS UMR 7593, Pavillon Clérambault, Hôpital de la Salpêtrière, 47, Bd. de l'H ôpital, 75013, Paris, France
*
*Correspondence and reprints.
Get access

Summary

Studies on the enhancing effects of nicotine on performance are usually pharmacological challenges using deprived male smokers. However, gender may be a factor that influences nicotine/smoking effects upon information processing. We investigated gender differences in contingent negative variation (CNV) amplitude in non-deprived dependent smokers performing a go-no go reaction time paradigm. Female smokers did not differ from female non-smokers in both early and late CNV, whereas male smokers presented greater early and late CNV compared to male non-smokers and an alteration in inhibiting processes responsible for CNV development in the no go condition. Consistent with the evidence of gender differences in nicotine/smoking sensitivity, these preliminary results emphasize the need for taking into account gender in psychophysiological research of nicotine/smoking effects.

Type
Short communication
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashton, HMarsh, VRJe, MRawlins, MDTelford, RThompson, JW.Biphasic dose-related responses of CNV (contingent negative variation) to i.v. nicotine in man. Br J Clin Pharmacol 1980; 10: 579–89.CrossRefGoogle ScholarPubMed
Benowitz, NLHatsukami, D.Pharmacokinetic considerations in understanding nicotine dependence. The biology of nicotine dependence. City: Wiley C.C.F.S; 1990. p. 186209.Google Scholar
Benowitz, NLHatsukami, D.Gender differences in the pharmacology of nicotine addiction. Addict Biol 1998; 3: 383404.CrossRefGoogle ScholarPubMed
Gevins, ACutillo, B.Signals of cognition. Handbook of electroencephalography and clinical neurophysiology. Lopez da Silva, F.HStorm van Leeuwen, WRémond, A, Eds.; Amsterdam: Elsevier/North Holland; 1990. 335–81.Google Scholar
Heartherton, TFKozlowski, LTFrecker, RCFagerström, KE.The Fagerström test for nicotine dependance: a revision of the Fargerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119–27.CrossRefGoogle Scholar
Ikard, FFTomkins, S.The experience of affect as a determinant of smoking: a series of validity studies. J Abnorm Psychol 1973; 81: 172–81.CrossRefGoogle ScholarPubMed
Mitchell, SH.Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology 1999; 146: 455–64.CrossRefGoogle ScholarPubMed
Norton, RHoward, R.Smoking, mood and the contingent negative variation (CNV) in a go-no go avoidance task. J Psychophysiol 1988; 2: 109–18.Google Scholar
Perkins, KA.Sex differences in nicotine versus non nicotine reinforcement as determinant of tobacco smoking. Exp Clin Psychopharmacol 1996; 4: 166–77.CrossRefGoogle Scholar
Perkins, KA.Nicotine discrimination in men and women. Pharmacol Biochem Behav 1999; 64: 295–9.CrossRefGoogle ScholarPubMed
Pierson, APartiot, AJouvent, RBungener, CMartinerie, JRenault, B., et al. Loss of control of pre-motor activation in anxious agitated and impulsive depressives. A clinincal and ERP study. Prog Neuro-Psychopharmacol Biol Psychiatry 1994; 18: 1037–50.CrossRefGoogle Scholar
Pritchard, WS.Electroencephalographic effects of cigarette smoking. Psychopharmacology 1991; 104: 485–90.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.